Stock Market & Financial Investment News

News Breaks June 20, 2012 07:42 EDT ONXX, SNY The FDA Oncologic Drugs Advisory Committee to hold a meeting The Committee discusses Sanofi-Aventis's New Drug Application (NDA) 203213 with the established name Semuloparin Sodium injection for the proposed indication for the prophylaxis of venous thromboembolism (VTE) in patients receiving chemotherapy for locally advanced or metastatic pancreatic or lung cancer. Also to be discussed is Onyx Pharmaceuticals' New Drug Application (NDA) 202714 with the proposed trade name Kyprolis (Carfilzomib) for treatment of patients with relapsed and refractory (recurring and/or not responsive to other treatments) multiple myeloma. The meeting is being held at the FDA Silver Spring, Maryland campus on June 20 at 8 am. Webcast Link News For ONXX;SNY From The Last 14 Days Check below for free stories on ONXX;SNY the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 18, 2013 08:38 EDT SNY Sanofi management to meet with JPMorgan Subscribe for More Information June 13, 2013 11:02 EDT SNY Leerink's major pharma analyst holds an analyst/Industry conference call Subscribe for More Information 07:57 EDT ONXX European Hematology Association to host annual meeting Annual Meeting of the EHA will be held in Stockholm, Sweden on June 13-16. June 10, 2013 07:20 EDT SNY Biomed to host a conference Subscribe for More Information 07:03 EDT SNY Sanofi announces FDA approved sBLA for licensure of influenza vaccine Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.